{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T10:56:07Z","timestamp":1782989767214,"version":"3.54.5"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2013,9,19]],"date-time":"2013-09-19T00:00:00Z","timestamp":1379548800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0074917","type":"journal-article","created":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T01:33:31Z","timestamp":1379640811000},"page":"e74917","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["Khellin and Visnagin Differentially Modulate AHR Signaling and Downstream CYP1A Activity in Human Liver Cells"],"prefix":"10.1371","volume":"8","author":[{"given":"Radim","family":"Vrzal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Frauenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Proksch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Abel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenek","family":"Dvorak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Haarmann-Stemmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,9,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2174\/138920011795016818","article-title":"Endogenous and exogenous ligands of aryl hydrocarbon receptor: current state of art","volume":"12","author":"L Stejskalova","year":"2011","journal-title":"Curr Drug Metab"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1515\/bc.2010.128","article-title":"An introduction to the molecular basics of aryl hydrocarbon receptor biology","volume":"391","author":"J Abel","year":"2010","journal-title":"Biol Chem"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1073\/pnas.97.2.779","article-title":"Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor","volume":"97","author":"Y Shimizu","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1046\/j.1365-2443.1997.1490345.x","article-title":"Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor","volume":"2","author":"J Mimura","year":"1997","journal-title":"Genes Cells"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/taap.1996.0210","article-title":"Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity","volume":"140","author":"PM Fernandez-Salguero","year":"1996","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1021\/bi061925f","article-title":"Rapid activation of c-Src kinase by dioxin is mediated by the Cdc37-HSP90 complex as part of Ah receptor signaling in MCF10A cells","volume":"46","author":"S Park","year":"2007","journal-title":"Biochemistry"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/138920008783571774","article-title":"Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues","volume":"9","author":"P Pavek","year":"2008","journal-title":"Curr Drug Metab"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.bcp.2008.09.013","article-title":"Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways","volume":"77","author":"T Haarmann-Stemmann","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"8851","DOI":"10.1073\/pnas.0701764104","article-title":"Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation","volume":"104","author":"E Fritsche","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00204-010-0548-2","article-title":"Regulation of dioxin receptor function by different beta-carboline alkaloids","volume":"84","author":"T Haarmann-Stemmann","year":"2010","journal-title":"Arch Toxicol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/BF02977334","article-title":"The effects of rutaecarpine on the pharmacokinetics of acetaminophen in rats","volume":"30","author":"SK Lee","year":"2007","journal-title":"Arch Pharm Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1211\/0022357055489","article-title":"Alteration of the pharmacokinetics of theophylline by rutaecarpine, an alkaloid of the medicinal herb Evodia rutaecarpa, in rats","volume":"57","author":"YF Ueng","year":"2005","journal-title":"J Pharm Pharmacol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1056\/NEJM195103012440901","article-title":"Khellin in the treatment of angina pectoris","volume":"244","author":"HL Osher","year":"1951","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/01.CIR.3.1.80","article-title":"Studies on the Effect of Oral and Parenteral Administration of Visammin (Khellin) in Patients with Angina Pectoris","volume":"3","author":"RC Scott","year":"1951","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0014-2999(95)00418-K","article-title":"Vasodilator effects of visnagin in isolated rat vascular smooth muscle","volume":"286","author":"J Duarte","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1055\/s-2006-959426","article-title":"The involvement of a Ca2+ channel blocking mode of action in the pharmacology of Ammi visnaga fruits","volume":"60","author":"HW Rauwald","year":"1994","journal-title":"Planta Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s12272-010-1117-1","article-title":"Anti-inflammatory effect of visnagin in lipopolysaccharide-stimulated BV-2 microglial cells","volume":"33","author":"JK Lee","year":"2010","journal-title":"Arch Pharm Res"},{"key":"ref18","article-title":"Fabricant DS, Farnsworth NR","year":"2001"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3390\/molecules16031956","article-title":"Synthesis of new visnagen and khellin furochromone pyrimidine derivatives and their anti-inflammatory and analgesic activity","volume":"16","author":"AA Abu-Hashem","year":"2011","journal-title":"Molecules"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1016\/j.ejmech.2010.07.065","article-title":"Preparation of new polycyclic compounds derived from benzofurans and furochromones. An approach to novel 1,2,3-thia-, and selena-diazolofurochromones of anticipated antitumor activities","volume":"45","author":"SM Atta","year":"2010","journal-title":"Eur J Med Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1248\/cpb.58.1148","article-title":"Synthesis and anticonvulsant activity of certain substituted furochromone, benzofuran and flavone derivatives","volume":"58","author":"FA Ragab","year":"2010","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00240-010-0333-y","article-title":"Prevention of renal crystal deposition by an extract of Ammi visnaga L. and its constituents khellin and visnagin in hyperoxaluric rats","volume":"39","author":"P Vanachayangkul","year":"2011","journal-title":"Urol Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1468-3083.2010.03701.x","article-title":"Treatment of vitiligo with khellin liposomes, ultraviolet light and blister roof transplantation","volume":"25","author":"J de Leeuw","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/1523-1747.ep13083852","article-title":"Phototherapeutic, photobiologic, and photosensitizing properties of khellin","volume":"90","author":"P Morliere","year":"1988","journal-title":"J Invest Dermatol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1021\/bi061460t","article-title":"Structural and functional characterization of the aryl hydrocarbon receptor ligand binding domain by homology modeling and mutational analysis","volume":"46","author":"A Pandini","year":"2007","journal-title":"Biochemistry"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.bcp.2004.11.017","article-title":"Natural furocoumarins as inducers and inhibitors of cytochrome P450 1A1 in rat hepatocytes","volume":"69","author":"A Baumgart","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1755-148X.2010.00762.x","article-title":"The aryl hydrocarbon receptor (AHR), a novel regulator of human melanogenesis. Pigment Cell","volume":"23","author":"S Luecke","year":"2010","journal-title":"Melanoma Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/jid.2010.269","article-title":"The aryl hydrocarbon receptor mediates UVB radiation-induced skin tanning","volume":"131","author":"B Jux","year":"2011","journal-title":"J Invest Dermatol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"10133","DOI":"10.1021\/es2029334","article-title":"Novel stably transfected gene reporter human hepatoma cell line for assessment of aryl hydrocarbon receptor transcriptional activity: construction and characterization","volume":"45","author":"A Novotna","year":"2011","journal-title":"Environ Sci Technol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.bcp.2007.09.013","article-title":"JNK inhibitor SP600125 is a partial agonist of human aryl hydrocarbon receptor and induces CYP1A1 and CYP1A2 genes in primary human hepatocytes","volume":"75","author":"Z Dvorak","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1289\/ehp.7793","article-title":"Polychlorinated biphenyls disturb differentiation of normal human neural progenitor cells: clue for involvement of thyroid hormone receptors","volume":"113","author":"E Fritsche","year":"2005","journal-title":"Environ Health Perspect"},{"key":"ref32","first-page":"143","article-title":"Adenovirus E1A orchestrates the urokinase-plasminogen activator system and upregulates PAI-2 expression, supporting a tumor suppressor effect","volume":"28","author":"V Fern\u00e1ndez-Soria","year":"2006","journal-title":"Int J Oncol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1248\/bpb.26.1379","article-title":"Specific inhibition of hypoxia-inducible factor (HIF)-1 alpha activation and of vascular endothelial growth factor (VEGF) production by flavonoids","volume":"26","author":"Y Hasebe","year":"2003","journal-title":"Biol Pharm Bull"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/toxsci\/55.1.107","article-title":"Ah receptor-based chemical screening bioassays: application and limitations for the detection of Ah receptor agonists","volume":"55","author":"SD Seidel","year":"2000","journal-title":"Toxicol Sci"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jhazmat.2007.07.022","article-title":"Differential effect of arecoline on the endogenous dioxin-responsive cytochrome P450 1A1 and on a stably transfected dioxin-responsive element-driven reporter in human hepatoma cells","volume":"149","author":"HR Chao","year":"2007","journal-title":"J Hazard Mater"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1006\/abbi.1995.1062","article-title":"Identification of 3&apos;-methoxy-4&apos;-nitroflavone as a pure aryl hydrocarbon (Ah) receptor antagonist and evidence for more than one form of the nuclear Ah receptor in MCF-7 human breast cancer cells","volume":"316","author":"YF Lu","year":"1995","journal-title":"Arch Biochem Biophys"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/mutage\/13.4.385","article-title":"Inhibition of metabolic activation of the promutagens, benzo[a]pyrene, 2-aminofluorene and 2-aminoanthracene by furanochromones in Salmonella typhimurium","volume":"13","author":"O Schimmer","year":"1998","journal-title":"Mutagenesis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0165-1218(95)90070-5","article-title":"Inhibition of mutagenesis of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) by coumarins and furanocoumarins, chromanones and furanochromanones","volume":"345","author":"R Edenharder","year":"1995","journal-title":"Mutat Res"},{"key":"ref39","first-page":"1029","article-title":"CYP1A1 specificity of Verlukast epoxidation in mice, rats, rhesus monkeys, and humans","volume":"21","author":"SJ Grossman","year":"1993","journal-title":"Drug Metab Dispos"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/026988110001400403","article-title":"Clozapine pharmacokinetics and pharmacodynamics studied with Cyp1A2-null mice","volume":"14","author":"KJ Aitchison","year":"2000","journal-title":"J Psychopharmacol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF00280138","article-title":"Verapamil and drug metabolism by the cytochrome P450 isoform CYP1A2","volume":"42","author":"U Fuhr","year":"1992","journal-title":"Eur J Clin Pharmacol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"9776","DOI":"10.1073\/pnas.93.18.9776","article-title":"17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1","volume":"93","author":"CL Hayes","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.canlet.2004.04.014","article-title":"Skin and salivary gland carcinogenicity of 7,12-dimethylbenz[a]anthracene is equivalent in the presence or absence of aryl hydrocarbon receptor","volume":"214","author":"F Ide","year":"2004","journal-title":"Cancer Lett"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.1211600","article-title":"Langerhans cells facilitate epithelial DNA damage and squamous cell carcinoma","volume":"335","author":"BG Modi","year":"2012","journal-title":"Science"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"33101","DOI":"10.1074\/jbc.M011497200","article-title":"Structure and expression of the Ah receptor repressor gene","volume":"276","author":"T Baba","year":"2001","journal-title":"J Biol Chem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1124\/dmd.107.016253","article-title":"Analysis of the transcriptional regulation and molecular function of the aryl hydrocarbon receptor repressor in human cell lines","volume":"35","author":"T Haarmann-Stemmann","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1515\/BC.2006.147","article-title":"The arylhydrocarbon receptor repressor (AhRR): structure, expression, and function","volume":"387","author":"T Haarmann-Stemmann","year":"2006","journal-title":"Biol Chem"},{"key":"ref48","first-page":"640","article-title":"The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers","volume":"118","author":"E Zudaire","year":"2008","journal-title":"J Clin Invest"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrc2400","article-title":"Revisiting the biological roles of PAI2 (SERPINB2) in cancer","volume":"8","author":"DR Croucher","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1925598","article-title":"Targets for dioxin: genes for plasminogen activator inhibitor-2 and interleukin-1 beta","volume":"254","author":"TR Sutter","year":"1991","journal-title":"Science"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/B978-0-12-386503-8.00006-5","article-title":"Role of the VEGF\/VEGFR axis in cancer biology and therapy","volume":"114","author":"A Rapisarda","year":"2012","journal-title":"Adv Cancer Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nature04479","article-title":"Endothelial cells and VEGF in vascular development","volume":"438","author":"L Coultas","year":"2005","journal-title":"Nature"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1124\/mol.107.044669","article-title":"Roles of cytosolic phospholipase A2 and Src kinase in the early action of 2,3,7,8-tetrachlorodibenzo-p-dioxin through a nongenomic pathway in MCF10A cells","volume":"74","author":"B Dong","year":"2008","journal-title":"Mol Pharmacol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.taap.2004.01.010","article-title":"The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes","volume":"199","author":"A Parkinson","year":"2004","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0190-9622(88)70092-4","article-title":"Treatment of vitiligo with khellin and ultraviolet A","volume":"18","author":"B Ortel","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejpb.2012.11.025","article-title":"Rationale of using Vinca minor Linne dry extract phytocomplex as a vincamine\u2019s oral bioavailability enhancer","volume":"84","author":"D Hasa","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0190-9622(89)80248-8","article-title":"Marked increase of liver transaminases after khellin and UVA therapy","volume":"21","author":"P Duschet","year":"1989","journal-title":"J Am Acad Dermatol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0074917","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T18:14:54Z","timestamp":1688494494000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0074917"}},"subtitle":[],"editor":[{"given":"Alok","family":"Deoraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,9,19]]},"references-count":57,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,9,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0074917","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,19]]}}}